StickWithANose

In its push for Health Care reform, the Obama administration has made a series of deals with various stake-holders in the health care industry in order to get them to play ball, and these deals with devils are going to be paid for by a middle class that is already under siege.

Big Pharma is on the road to getting its deal: not only 25 to 30 million more paying customers, but also a continued ban on Medicare using its bargaining clout to reduce drug prices, a bar on genetic drug manufacturers introducing similar biologic drugs until the originals have been on the market at least twelve years, and no public insurance option to negotiate low drug prices. (Big Pharma did agree to $80 billion of cost cuts over the next ten years, to be sure, but its hush money payoffs far exceeded that sum.)

Big insurance is well on the way to getting what it wants: 25 to 30 million more paying customers (many of them young and healthy), a requirement that almost all businesses “pay or play,” and no competition from a public option.

Doctors (that is, the American Medical Association) are on the way to getting what they want: Instead of a temporary patch on scheduled decreases in Medicare reimbursements to them, a permanent fix that would change the reimbursement formula altogether and reward them $240 billion over the next ten years.

But when they all get paid off, who will do the paying? Middle-class Americans who are already in a financial squeeze — whose wages are lower, adjusted for inflation, than they were thirty years ago, and whose jobs are disappearing. They’ll face still higher premiums, co-payments, and deductibles; and they’ll pay higher drug prices, Medicare premiums, and taxes to cover the rest.